Press Releases

ALLAN BOWDITCH, EX-CEO OF GLOBAL HEALTHCARE FOR MARTIN HAMBLIN, JOINS FORCES WITH THE ZIMENT GROUP

NEW YORK, February 1, 2006 – Allan Bowditch, a renowned and sought after healthcare researcher responsible for building Martin Hamblin's healthcare business over a 30 year period, has joined The Ziment Group in a Strategic Advisor role.

"Having known and competed with Allan for years I felt it was high time to get him on our team" said Howard Ziment, Chief Executive Officer of The Ziment Group. "He brings a depth of knowledge of our industry that is unparalleled. We are thrilled to bring someone with such a sterling reputation for being one of the best global healthcare market researchers in the history of our industry to our halls."

Bowditch was CEO of Martin Hamblin until May of 2004. He was in an advisory role to that company through mid-2005.

“The Ziment Group is a dynamic, diverse organization", said Bowditch. "The opportunity to bring the expertise I have built throughout my career to such a place has limitless possibilities."

In his role as Strategic Advisor, Bowditch will assist The Ziment Group in many ways, including the continued building of Ziment's European efforts; in product development for all group companies and in the training and development of Ziment staff including moderators, analytic and project staff. He will also continue his work in supporting the healthcare and pharmaceutical marketing research industries through his work with industry associations.

"Having someone with the stature of Allan joining our organization will really help build upon the terrific momentum we have in our primary research business in Europe," said Andrew Scott, Managing Director, Ziment Europe. "We look forward to a terrific year in 2006."

In 2003 Bowditch was given a Special Award for his contribution to Global Marketing Research by EphMRA (European Pharmaceutical Market Research Association) across his career. In 2005, he was given a lifetime achievement award by PBIRG (Pharmaceutical Business Intelligence Research Group), an organization of US based pharmaceutical companies who conduct global market research.

About The Ziment Group:

The Ziment Group consists of Ziment, a full service consultancy offering custom marketing research for the healthcare and pharmaceutical industries worldwide; WebSurveyResearch which houses the largest dedicated panel of physicians with which to conduct  marketing research through the internet; imap Research, a division dedicated to conducting syndicated market tracking research; and Consumer Health Sciences, which conducts the National Health and Wellness Survey (nhwsurvey.com), the pre-eminent source of information about the flow of patients into physicians' offices.

The Ziment Group is the global healthcare research brand for The Kantar Group, the Information and Consultancy Division of WPP, plc.  For more information on the group and its divisions, go to www.zimentgroup.com.

<< back